Febuxostat is a novel non-purine selective inhibitor of xanthine oxidase for the management ... Febuxostat is available as 40- and 80-mg tablets. The recommended starting dosage is 40 mg orally ...

The patent covers compositions and methods of formulating using XORTX’s proprietary formulations of xanthine oxidase inhibitors (“XOI”) for the treatment of health consequences of chronically high ...

Allopurinol is a xanthine oxidase inhibitor, recommended for treating the increased uric acid levels caused by cancer drugs.